| Rank | Ticker | Country | Price | Revenue | Analyst Rating | Analysts | IPO Year |
|---|---|---|---|---|---|---|---|
#1 | LYFT | United States | $13.37 | $6,316,261,000.00 | Buy | 31 | 2019 |
#2 | INCY | United States | $99.73 | $3,394,635,000.00 | Buy | 21 | 1994 |
#3 | TOST | United States | $26.50 | $6,153,000,000.00 | Buy | 24 | 2021 |
#4 | TRMB | United States | $67.55 | $3,798,700,000.00 | Buy | 7 | 1996 |
#5 | VRRM | United States | $15.69 | $132,969,000.00 | Buy | 5 | 2016 |
#6 | VECO | United States | $28.51 | $717,301,000.00 | Buy | 5 | 1996 |
#7 | TTI | United States | $10.94 | $0.00 | Strong Buy | 5 | 1996 |
#8 | TRUP | United States | $26.33 | $1,439,305,000.00 | Buy | 4 | 2014 |
#9 | PTCT | United States | $67.73 | $264,734,000.00 | Buy | 17 | 2006 |
#10 | RKT | United States | $17.20 | $0.00 | Buy | 14 | 2020 |
#11 | NTNX | United States | $37.66 | $2,537,927,000.00 | Buy | 16 | 2015 |
#12 | QTWO | United States | $47.35 | $193,978,000.00 | Buy | 13 | 2014 |
#13 | KNSA | United Kingdom | $42.92 | $677,564,000.00 | Strong Buy | 7 | 2018 |
#14 | DT | United States | $34.84 | $1,698,683,000.00 | Strong Buy | 23 | 2019 |
#15 | SBGI | United States | $13.68 | $3,548,000,000.00 | Buy | 5 | 2023 |
#16 | EVER | United States | $16.08 | $163,349,000.00 | Strong Buy | 5 | 2018 |
#17 | DOCN | United States | $59.79 | $901,427,000.00 | Buy | 14 | 2021 |
#18 | INSP | United States | $59.23 | $82,050,000.00 | Buy | 16 | 2018 |
#19 | KD | United States | $12.11 | $15,057,000,000.00 | Buy | 5 | 2021 |
#20 | AORT | United States | $35.44 | $298,836,000.00 | Strong Buy | 5 | 1996 |
#21 | LC | United States | $15.95 | $314,702,000.00 | Buy | 6 | 2008 |
#22 | BWMN | United States | $32.75 | $426,564,000.00 | Strong Buy | 5 | 2021 |
#23 | LTH | United States | $25.43 | $2,995,255,000.00 | Strong Buy | 7 | 2021 |
#24 | AFRM | United States | $48.28 | $3,224,412,000.00 | Buy | 29 | 2020 |
#25 | WGO | United States | $42.05 | $1,985,674,000.00 | Buy | 12 | 1994 |
#26 | BOX | United States | $22.62 | $506,142,000.00 | Buy | 7 | 2014 |
#27 | OKTA | United States | $71.43 | $2,610,000,000.00 | Buy | 37 | 2017 |
#28 | VITL | United States | $25.03 | $606,307,000.00 | Strong Buy | 9 | 2020 |
#29 | ARWR | United States | $62.55 | $16,142,321.00 | Strong Buy | 11 | 2009 |
#30 | DKNG | United States | $22.59 | $6,054,525,000.00 | Strong Buy | 29 | 2021 |
#31 | GTLB | United States | $25.08 | $759,249,000.00 | Buy | 27 | 2021 |
#32 | EXTR | United States | $13.81 | $1,140,067,000.00 | Strong Buy | 5 | 1999 |
#33 | RVLV | United States | $23.30 | $1,129,911,000.00 | Buy | 13 | 2018 |
#34 | ATRC | United States | $31.16 | $201,630,000.00 | Strong Buy | 7 | 2005 |
#35 | HQY | United States | $75.68 | $229,525,000.00 | Buy | 15 | 2014 |
#36 | SHC | United States | $16.21 | $1,163,617,000.00 | Buy | 7 | 2020 |
#37 | TREE | United States | $35.66 | $900,219,000.00 | Strong Buy | 5 | 2008 |
#38 | IDYA | United States | $32.12 | $218,710,000.00 | Strong Buy | 16 | 2019 |
#39 | AZTA | United States | $28.24 | $593,821,000.00 | Strong Buy | 5 | 1996 |
#40 | NDAQ | United States | $84.04 | $4,277,000,000.00 | Buy | 14 | 2001 |
#41 | DRVN | United States | $10.30 | $2,339,588,000.00 | Buy | 9 | 2020 |
#42 | PHR | United States | $11.78 | $419,813,000.00 | Strong Buy | 17 | 2019 |
#43 | PFSI | United States | $91.41 | $984,629,000.00 | Buy | 8 | 2018 |
#44 | BSX | United States | $74.61 | $9,076,000,000.00 | Strong Buy | 20 | 2010 |
#45 | ZM | United States | $84.71 | $4,665,433,000.00 | Buy | 23 | 2019 |
#46 | OMF | United States | $55.57 | $0.00 | Buy | 12 | 2013 |
#47 | DOCS | United States | $24.17 | $570,399,000.00 | Buy | 19 | 2021 |
#48 | WK | United States | $57.75 | $884,568,000.00 | Strong Buy | 11 | 2014 |
#49 | INTA | United States | $21.26 | $504,120,000.00 | Buy | 8 | 2021 |
#50 | MXL | United States | $18.36 | $478,596,000.00 | Buy | 5 | 2009 |
The FinQuota filters have identified what they believe to be the "Best Stocks Under $100 to Buy (February 25, 2026) | FinQuota" to buy now. However, please note that this information should not be considered as financial advice, as investing involves risks. We strongly recommend consulting with a qualified financial advisor before making any decisions regarding buying or selling stocks.